Compounding pharmacies will no longer be allowed to create semaglutide injections, a generic and cheaper version of Ozempic and Wegovy. This comes after a judge rejected a bid by these pharmacies to ...

Harvard Medical School experts reported that a rapid loss of fat in the face can cause a hollowed look to the face; changes ...

Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run ...

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final resolution.

Popular medications for obesity and diabetes have been linked to an increased risk of hair loss, particularly for women. Researchers and doctors weigh in.

However, patients who didn't take semaglutide beforehand quickly caught up and had no difference in combined ... have found ...

The FDA has said there is no longer a shortage ... was blocked in December after that also came off the shortage list. The end of the official shortage status for semaglutide came as telehealth ...

Previous studies have found that taking semaglutide after ... before surgery plateaued at the same percent lost at the six-, nine-, and 12-month marks. The researchers also found that the number and ...

“We have heard this anecdotally when patients consult us for surgical restoration of their face after rapid ... he noted — “and semaglutide-driven loss is likely no exception.” ...

A US judge has rejected efforts by a compounded drugs industry group to keep making an alternative version of Novo Nordisk’s popular drug semaglutide, opening the door for the US Food and Drug ...